Laboratory diagnosis and susceptibility profile of Helicobacter pylori infection in the Philippines

Annals of Clinical Microbiology and Antimicrobials

Volumn 3, Issue , 2004, Pages

  Destura, Raul V ^a,b   Labio, Eternity D ^b   Barrett, Leah J ^a   Alcantara, Cirle S ^a,b,c   Gloria, Venancio I ^b   Daez, Ma Lourdes O ^b   Guerrant, Richard L ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b PHILIPPINE GENERAL HOSPITAL   (Philippines)

^c UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; TETRACYCLINE; UREASE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG CHOICE; DYSPEPSIA; ENDOSCOPY; FEMALE; GENERAL HOSPITAL; GRAM STAINING; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OUTPATIENT DEPARTMENT; PATIENT CARE; PHILIPPINES; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL; STOMACH BIOPSY;

EID: 25844500899     PISSN: 14760711     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-3-25     Document Type: Article

References (30)

1. Go MF: Treatment and management of Helicobacter pylori infection. Curr Gastroenterol Rep 2002, 4:471-477.
2. Poon SK, Chang CS, Su J, Lai CH, Yang CC, Chen GH, Wang WC: Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori iansoprazole-based triple therapies. Aliment Pharmacol Ther 2002, 16:291-296.
3. Glupczynski Y, Megraud F, Lopez-Brea M, Andersen LP: European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori. Eur J Clin Microbiol Infect Dis 2001, 20:820-823.
4. Go MF: Review article: natural history and epidemiology of Helicobacter pylori infection. Aliment Pharmacol Ther 2002, 16 Suppl 1:3-15.
5. Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, Richards ID, Dowell AC, Forman D: Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection. Int J Epidemiol 2002, 31:624-631.
6. Adeyemi EO, Danial MF, Helal T, Benedict S, Abdulle AM: The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate. Eur J Gastroenterol Hepatol 1999, 11:1259-1263.
7. Grove DI, Koutsouridis G, Cummins AG: Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycilin, clarithromycin, metronidazole and tetracycline. Pathology 1998, 30:183-187.
8. Bailey and Scott's Diagnostic Microbiology 8th edition. Edited by: E B and S F. The C.V. Mosby Company; 1990:440-440.
9. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing. Approved standard M7-A5. Informational supplement M100-S10. NCCLS, Wayne, PA. 2000.
10. Megraud F, Lehn N, Lind T, Bayerdorffer E, O'Morain C, Spiller R, Unge P, van Zanten SV, Wrangstadh M, Burman CF: Antimicrobial susceptibility testing of Helicobacter pylori in a large multi-center trial: the MACH 2 study. Antimicrob Agents Chemother 1999, 43:2747-2752.
11. Tolia V, Brown W, El Baba M, Lin CH: Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J 2000, 19:1167-1171.
12. Kwon DH, Kim JJ, Lee M, Yamaoka Y, Kato M, Osato MS, El Zaatari FA, Graham DY: Isolation and characterization of tetracycline-resistant clinical isolates of Helicobacter pylori. Antimicrob Agents Chemother 2000, 44:3203-3205.
13. Ozcay F, Kocak N, Temizel IN, Demir H, Ozen H, Yuce A, Gurakan F: Helicobacter pylori infection in Turkish children: comparison of diagnostic tests, evaluation of eradication rate, and changes in symptoms after eradication. Helicobacter 2004, 9:242-248.
14. Fabre R, Sobhani I, Laurent-Puig P, Hedef N, Yazigi N, Vissuzaine C, Rodde I, Potet F, Mignon M, Etienne JP,.: Polymerase chain reaction assay for the detection of Helicobacter pylori in gastric biopsy specimens: comparison with culture, rapid urease test, and histopathological tests. Gut 1994, 35:905-908.
15. Weiss J, Mecca J, da Silva E, Gassner D: Comparison of PCR and other diagnostic techniques for detection of Helicobacter pylori infection in dyspeptic patients. J Clin Microbiol 1994, 32:1663-1668.
16. Lage AP, Godfroid E, Fauconnier A, Burette A, Butzler JP, Bollen A, Glupczynski Y: Diagnosis of Helicobacter pylori infection by PCR: comparison with other invasive techniques and detection of cagA gene in gastric biopsy specimens. J Clin Microbiol 1995, 33:2752-2756.
17. Montes H, Salmen S, Dolfo W, Sotolongo A, Petrosino P, Donis J, Berrueta L: Evaluation of a liquid urease test (LUT) for detection of Helicobacter pylori. Acta Gastroenterol Latinoam 2003, 33:73-76.
18. Kuo CH, Wu DC, Lu CY, Su YC, Yu FJ, Lee YC, Wu IC, Lin SR, Liu CS, Jan CM, Wang WM: The media of rapid urease test influence the diagnosis of Helicobacter pylori. Hepatogastroenterology 2002, 49:1191-1194.
19. Ikezawa K, Kashimura H, Kojima M, Aikawa T, Nakahara A, Mutoh H, Tanaka N: Pretreatment antimicrobial susceptibilities of paired gastric Helicobacter pylori isolates: antrum versus corpus. Helicobacter 1999, 4:218-221.
20. Kato S, Fujimura S, Udagawa H, Shimizu T, Maisawa S, Ozawa K, Iinuma K: Antibiotic resistance of Helicobacter pylori strains in Japanese children. J Clin Microbiol 2002, 40:649-653.
21. Kim JJ, Reddy R, Lee M, Kim JG, El Zaatari FA, Osato MS, Graham DY, Kwon DH: Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001, 47:459-461.
22. Meyer JM, Silliman NP, Wang W, Siepman NY, Sugg JE, Morris D, Zhang J, Bhattacharyya H, King EC, Hopkins RJ: Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann Intern Med 2002, 136:13-24.
23. Miyaji H, Azuma T, Ito S, Suto H, Ito Y, Yamazaki Y, Sato F, Hirai M, Kuriyama M, Kato T, Kohli Y: Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan. Aliment Pharmacol Ther 1997, 11:1131-1136.
24. Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F: Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig Liver Dis 2000, 32:763-768.
25. Wolle K, Leodolter A, Malfertheiner P, Konig W: Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002, 51:705-709.
26. Vicente R, Sicilia B, Gallego S, Revillo MJ, Ducons J, Gomollon F: [Helicobacter pylori eradication in patients with peptic ulcer after two treatment failures: a prospective culture-guided study]. Gastroenterol Hepatol 2002, 25:438-442.
27. Wong WM, Wong BC, Lu H, Gu Q, Yin Y, Wang WH, Fung FM, Lai KC, Xia HH, Xiao SD, Lam SK: One-week omeprazole, furazolidone and amoxicillin rescue therapy after failure of Helicobacter pylori eradication with standard triple therapies. Aliment Pharmacol Ther 2002, 16:793-798.
28. Lui SY, Yeoh KG, Ho B: Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population. J Clin Microbiol 2003, 41:5011-5014.
29. A. B: The antibiotic crisis. In problem drugs. 1993:51-68.
30. ER D: Inappropriate Antibiotic Use in the Philippines. Phil J Microbiol Infect 1997, 26:77-87 [http://www.psmid.org.ph/vol26/ vol26num2topic6.pdf].